Effects of vitamin D3 on selected biochemical parameters of nutritional status, inflammation, and cardiovascular disease in patients undergoing long-term hemodialysis

Polskie Archiwum Medycyny Wewnetrznej

Volumn 120, Issue 5, 2010, Pages 167-174

  Bednarek Skublewska, Anna ^a   Smoleń, Agata ^a   Jaroszyński, Andrzej ^a   Załuska, Wojciech ^a   Ksia̧zek, Andrzej ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Asymmetric dimethylarginine; Hemodialysis; Inflammation; Vitamin D3

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN; ALFACALCIDOL; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; COLECALCIFEROL; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 10; INTERLEUKIN 6; N(G),N(G) DIMETHYLARGININE; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BODY MASS; CARDIOVASCULAR DISEASE; COMORBIDITY; CORRELATION ANALYSIS; FEMALE; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; KIDNEY FAILURE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; VITAMIN BLOOD LEVEL; BLOOD; CHRONIC KIDNEY FAILURE; RENAL REPLACEMENT THERAPY; VITAMIN D DEFICIENCY;

AGED; CARDIOVASCULAR DISEASES; CHOLECALCIFEROL; FEMALE; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; MALE; NUTRITIONAL STATUS; RENAL DIALYSIS; VITAMIN D DEFICIENCY;

EID: 77953763637     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.917     Document Type: Article

References (43)

1. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune disease, cancers and cardiovascular disease. Am J Clin Nutr. 2004; 80 (6 Suppl): 1678S-1688S.
2. Heaney RP. Vitamin D in health and disease. Clin J Am Soc Nephrol. 2008; 3: 1535-1541.
3. Norman AW. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr. 2008; 88: 491S-499S.
4. Holick MF. Vitamin D status: measurement interpretation, and clinical application. Ann Epidemiol. 2009; 19: 73-78.
5. 3. Semin Dial. 2007; 20: 316-324.
6. Zittermann A, Schleithoff SS, Tenderach G, et al. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure. J Am Coll Cardiol. 2003; 41: 105-112. (Pubitemid 36044411)
7. Holick MF. Vitamin D: importance in prevention of cancers, type I diabetes, heart disease and osteoporosis. Am J Clin Nutr. 2004; 79: 362-371.
8. Schleithoff SS, Zittermann A, Tenderich G, et al. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2006; 38: 754-759.
9. Foumier A, Fardellone P, Achard JM, et al. Importance of vitamin D repletion in uraemia. Nephrol Dial Transplant. 1999; 14: 819-823.
10. 3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science. 1979; 206: 1188-1190.
11. 3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab. 1983: 57: 13008-13110.
12. Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin D levels and risk of mortality in the general population. Arch Intern Med. 2008; 11; 168: 1629-1637.
13. Wolf M, Shah A, Gutierrez O, et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. 2007; 72: 1004-1013.
14. Matias PJ, Ferreira C, Jorge C, et al. 25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in hemodialysis patients. Nephrol Dial Transplant. 2009; 24: 611-618.
15. Coen G. Vitamin D: an old prohormone with an emergent role in chronic kidney disease. J Nephrol. 2008: 21: 313-323.
16. González EA, Sachdeva A, Oliver DA, Martin KJ. Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol 2004; 24: 503-510.
17. Charlson ME, Popei P, Ales KL, et al. A new method of classifying co-morbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40: 373-83.
18. Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V an analysis of error. J Am Soc Nephrol. 1993; 4: 1205-1213.
19. NKF-K/DOQI. Nutrition Work Group Clinical Practice Guidelines for nutrition in chronic renal failure. National Kidney Foundation. New York; 2001: 75-80.
20. Erkal MZ, Wilde J, Bilgin Y, et al. High prevalence of vitamin D deficiency, secondary hyperparathyroidism and generalized bone pain in Turkish immigrants in Germany: identification of risk factors. Osteoporos Int. 2006; 17: 1133-1140.
21. Napiórkowska L, Budlewski T, Jakubas-Kwiatkowska W, et al. Prevalence of low serum vitamin D concentration in an urban population of elderly women in Poland. Pol Arch Med Wewn. 2009; 119: 699-703.
22. Del Valle E, Negri AL, Aguirre C, et al. Prevalence of 25 (OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis. Hemodial Int. 2007; 11: 315-321.
23. Pecovnik-Balon B, Jakopin E, Bevc S. Vitamin D as a novel non-traditional risk factor for mortality in hemodialysis patients. Ther Apher Dial. 2009; 13: 268-72.
24. 3. J Clin Invest. 1985; 76: 1536-1538.
25. Holick MF, Matsuoka LY, Wortsman J. Age, vitamin D, and solar ultraviolet Lancet. 1989; 1: 1104-1105.
26. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001; 22; 477-501.
27. Visser M, Deeg DJ, Puts MT, et al. Low serum concentration of 25-hydroxyvitamin D in older persons and the risk of nursing home admission. Am J Clin Nutr. 2006; 86: 616-622.
28. Bell NH, Epstein S, Greene A, et al. Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest. 1985; 76: 370-373. (Pubitemid 15243466)
29. Jean G, Charra B, Chazot C. Vitamin D deficiency and associated factors in hemodialysis patients. J Ren Nutr. 2008; 18: 395-399.
30. Zittermann A, Schleithoff SS, Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr. 2005; 94: 483-92. (Pubitemid 41555486)
31. Bronner F. Recent developments in intestinal calcium absorption. Nutr Rev. 2009; 62: 109-113.
32. Hammerer-Lercher A, Puschendorf B, Mair J. Cardiac natriuretic peptides: new laboratory parameters in heart failure patients. Clin Lab. 2001; 47: 265-277. (Pubitemid 32492873)
33. Hunt PJ, Richards AM, Nicholls MG, et al. Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment Clin Endocrinol (Oxf). 1997; 47: 287-296.
34. Banerjee P, Chatterjee M. Antiproliferative role of vitamin D and its analogs - a brief overview. Mol Cell Biochem. 2003; 253: 247-254. (Pubitemid 37321732)
35. Lukasiewicz M, Mroczko B, Szmitkowski M. [Clinical relevance of interleukin 6 (IL-6) as a prognostic factor in cancer). Pol Arch Med Wewn. 2007; 117: 247-251. Polish.
36. Li AC, Glass CK. The macrophage foam cell as a target of therapeutic intervention. Nat Med. 2002; 8: 1235-1242.
37. Foley RN, Parfrey PS, Harnett JD, et al. The impact of anemia on cardiomyopathy morbidity, and mortality in end stage renal disease. Am J Kidney Dis. 1996; 28: 53-61.
38. Sim JJ, Lac PT, Liu IL, et al. Vitamin D deficiency and anemia: a cross-sectional study. Ann Hematol. 2009; 89: 447-452.
39. Patel NM, Gutierrez OM, Andress DL, et al. Vitamin D deficiency and anemia in eariy chronic kidney disease. Kidney Int. 2010; 77: 715-720.
40. Böger RH, Zoccalli C. ADMA - a novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease. Atherosclerosis. 2003; 4: 23-28.
41. Kielstein J T, Zoccali C. Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age? Am J Kidney Dis. 2005; 46: 186-191.
42. Cooke JP. Asymmetrical dimethylarginine. The Uber marker? Circulation. 2004; 109: 1813-1818.
43. London GM, Guérin AP, Verbeke FH, et al. Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol. 2007; 18: 613-620.